At a glance
ClinicalIndex Comparison RecordN/ACompleted· 985 enrolled
Drug / intervention
CADDIEdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Artificial Intelligence for Detection of Gastrointestinal Lesions in Endoscopy (EAGLE)
In Brief
A clinical study evaluating CADDIE for Colorectal Cancer and 2 related conditions. Completed, enrolled 985 participants across 9 sites in 5 countries.
Detailed Summary
The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer, Polyp of Colon, Adenoma Colon
CountriesGeorgia, Germany, Italy, Poland, Spain
CollaboratorsMeditrial Europe Ltd.
Timeline
N/ACompletedFinished
202420252026
First PostedFeb 2023
Enrollment StartMay 2023
Primary CompletionNov 2023
Study CompletionNov 2023
TodayJul 2026
First PostedFeb 15, 2023
Enrollment StartMay 10, 2023
Primary CompletionNov 20, 2023
Study CompletionNov 29, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.4 years ago
Interventions
CADDIEdevice
A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.